Overview

Single-dose, Study of RBP-6000 in Opioid Dependent Individuals

Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability and pharmacokinetic profile of an injection of RBP-6000.
Phase:
Phase 1
Details
Lead Sponsor:
Indivior Inc.
Treatments:
Buprenorphine